17th annual and first virtual conference sponsored by Roche Tissue Diagnostics draws worldwide cancer experts to discuss innovations and discoveries that shape the future of personalized healthcare.
Tucson Symposium brings together more than 500 global thought leaders, pathologists, oncologists and scientific researchers to explore the latest hypotheses and breakthroughs in immune oncology, tumor biology, transforming technologies, precision medicine and artificial intelligence (AI) — all with the singular focus of improving patients' lives.
The Symposium, presented in real time, spans three half days and includes seven sessions featuring 23 globally recognized speakers, an interactive poster session and networking opportunities.
"The Tucson Symposium is a truly unique conference focusing on the latest discoveries and innovations in oncology, pathology and diagnostics,” said Dr. Eric Walk, Chief Medical & Scientific Officer, Roche Tissue Diagnostics. “For the 2021 virtual event, we are once again privileged to have the world’s top oncologists, pathologists and scientists present on a diverse array of topics including cancer immunotherapy, pathology applications of AI and deep learning, and targeted therapy advances in lung cancer.”
For more information and to register for Tucson Symposium, visit www.tucsonsymposium.com.
About Roche Tissue Diagnostics
Roche Tissue Diagnostics innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA products are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms and digital pathology solutions optimize laboratory efficiencies to support diagnosis, help reduce errors and enable informed treatment decisions. Together with Roche, the company is driving personalized healthcare through accelerated drug discovery and the development of companion diagnostics to identify the patients most likely to respond favorably to specific therapies. Visit go.roche.com/about-RTD.
Dr. Eric Walk